Raman spectroscopy demonstrates increased glycogen accumulation in skeletal muscle cells from Pompe patients, highlighting disease mechanisms.
Abstract Pompe disease is a genetic myopathy characterised by inadequate levels of lysosomal acid α-1,4-glucosidase (GAA). This deficiency leads to the abnormal accumulation of glycogen in lysosomes, primarily affecting skeletal muscle cells. As research and treatment options progress, accurate methods for evaluating glycogen storage are crucial. We employed Raman spectroscopy to analyse glycogen accumulation in primary muscle cells from patients with late-onset Pompe disease (LOPD) and healthy individuals. Our findings indicated a significant increase in glycogen in Pompe-derived muscle cells compared to controls, with unique glycogen signatures detected at the subcellular level. Notably, glycogen existed in two forms: small, round stores encased in lipids, recognised as lysosomes, and larger, more loosely defined areas of cytoplasmic glycogen. Moreover, precipitated glycogen was also noted. These results provide new insights into glycogen localisation and condition in Pompe disease, serving as a valuable tool for assessing therapeutic approaches targeting glycogen storage disorders.
No takes yet. Share an insight, caveat, or question.
Meinke et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: